Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1882 1
1884 1
1887 1
1923 1
1943 1
1944 1
1946 1
1947 1
1948 4
1950 1
1951 3
1952 3
1954 1
1955 1
1956 2
1958 1
1959 2
1961 1
1962 1
1963 1
1965 6
1966 2
1967 5
1968 2
1969 1
1970 2
1971 3
1972 3
1973 1
1974 3
1975 2
1976 3
1977 5
1978 4
1979 6
1980 7
1981 2
1982 2
1983 6
1985 9
1986 11
1987 5
1988 6
1989 13
1990 13
1991 15
1992 16
1993 22
1994 20
1995 34
1996 28
1997 18
1998 30
1999 13
2000 25
2001 19
2002 31
2003 29
2004 28
2005 45
2006 37
2007 32
2008 51
2009 53
2010 56
2011 61
2012 72
2013 73
2014 84
2015 108
2016 87
2017 100
2018 90
2019 115
2020 104
2021 118
2022 141
2023 121
2024 122
2025 124
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,025 results

Results by year

Filters applied: . Clear all
Page 1
Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective.
Sims EK, Besser REJ, Dayan C, Geno Rasmussen C, Greenbaum C, Griffin KJ, Hagopian W, Knip M, Long AE, Martin F, Mathieu C, Rewers M, Steck AK, Wentworth JM, Rich SS, Kordonouri O, Ziegler AG, Herold KC; NIDDK Type 1 Diabetes TrialNet Study Group. Sims EK, et al. Diabetes. 2022 Apr 1;71(4):610-623. doi: 10.2337/dbi20-0054. Diabetes. 2022. PMID: 35316839 Free PMC article. Review.
Omalizumab for the Treatment of Multiple Food Allergies.
Wood RA, Togias A, Sicherer SH, Shreffler WG, Kim EH, Jones SM, Leung DYM, Vickery BP, Bird JA, Spergel JM, Iqbal A, Olsson J, Ligueros-Saylan M, Uddin A, Calatroni A, Huckabee CM, Rogers NH, Yovetich N, Dantzer J, Mudd K, Wang J, Groetch M, Pyle D, Keet CA, Kulis M, Sindher SB, Long A, Scurlock AM, Lanser BJ, Lee T, Parrish C, Brown-Whitehorn T, Spergel AKR, Veri M, Hamrah SD, Brittain E, Poyser J, Wheatley LM, Chinthrajah RS. Wood RA, et al. N Engl J Med. 2024 Mar 7;390(10):889-899. doi: 10.1056/NEJMoa2312382. Epub 2024 Feb 25. N Engl J Med. 2024. PMID: 38407394 Free PMC article. Clinical Trial.
Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment.
Greene C, Connolly R, Brennan D, Laffan A, O'Keeffe E, Zaporojan L, O'Callaghan J, Thomson B, Connolly E, Argue R, Meaney JFM, Martin-Loeches I, Long A, Cheallaigh CN, Conlon N, Doherty CP, Campbell M. Greene C, et al. Nat Neurosci. 2024 Mar;27(3):421-432. doi: 10.1038/s41593-024-01576-9. Epub 2024 Feb 22. Nat Neurosci. 2024. PMID: 38388736 Free PMC article.
A famsin-glucagon axis mediates glucose homeostasis.
Long A, Wang Y, Guo Y, Hong J, Ning G, Meng Z, Wang J, Wang Y. Long A, et al. Cell Metab. 2025 Mar 4;37(3):629-639.e6. doi: 10.1016/j.cmet.2024.11.008. Epub 2024 Dec 19. Cell Metab. 2025. PMID: 39706194
Immune dysregulation.
Long A, Kleiner A, Looney RJ. Long A, et al. J Allergy Clin Immunol. 2023 Jan;151(1):70-80. doi: 10.1016/j.jaci.2022.11.001. J Allergy Clin Immunol. 2023. PMID: 36608984 Free article. Review.
An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor.
Reyes Gaido OE, Pavlaki N, Granger JM, Mesubi OO, Liu B, Lin BL, Long A, Walker D, Mayourian J, Schole KL, Terrillion CE, Nkashama LJ, Hulsurkar MM, Dorn LE, Ferrero KM, Huganir RL, Müller FU, Wehrens XHT, Liu JO, Luczak ED, Bezzerides VJ, Anderson ME. Reyes Gaido OE, et al. Sci Transl Med. 2023 Jun 21;15(701):eabq7839. doi: 10.1126/scitranslmed.abq7839. Epub 2023 Jun 21. Sci Transl Med. 2023. PMID: 37343080 Free PMC article.
PD-L2 is a second ligand for PD-1 and inhibits T cell activation.
Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, Chernova I, Iwai Y, Long AJ, Brown JA, Nunes R, Greenfield EA, Bourque K, Boussiotis VA, Carter LL, Carreno BM, Malenkovich N, Nishimura H, Okazaki T, Honjo T, Sharpe AH, Freeman GJ. Latchman Y, et al. Nat Immunol. 2001 Mar;2(3):261-8. doi: 10.1038/85330. Nat Immunol. 2001. PMID: 11224527
Juvenile Idiopathic Arthritis.
Long AM, Marston B. Long AM, et al. Pediatr Rev. 2023 Oct 1;44(10):565-577. doi: 10.1542/pir.2022-005623. Pediatr Rev. 2023. PMID: 37777651
Active Listening.
Tennant K, Long A, Toney-Butler TJ. Tennant K, et al. 2023 Sep 13. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Sep 13. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 28723044 Free Books & Documents.
2,025 results